Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: Acute and chronic effects

Brain Stimulation

Volumn 6, Issue 4, 2013, Pages 631-640

  Aaronson, Scott T ^a   Carpenter, Linda L ^b   Conway, Charles R ^c,d   Reimherr, Frederick W ^e   Lisanby, Sarah H ^f   Schwartz, Thomas L ^g   Moreno, Francisco A ^h   Dunner, David L ⁱ   Lesem, Michael D ^j   Thompson, Peter M ^k   Husain, Mustafa ^l   Vine, Craig J ^m   Banov, Michael D ⁿ   Bernstein, Lawrence P ^o   Lehman, Robert B ^p   Brannon, Guy E ^q   Keepers, George A ^r   O'Reardon, John P ^s,u   Rudolph, Richard L ^t   Bunker, Mark ^t  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

^b BROWN UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e Psychiatric and Behavioral Solutions   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^h UNIVERSITY OF ARIZONA   (United States)

ⁱ Center for Anxiety and Depression   (United States)

^j Claghorn Lesem Research Clinic Ltd   (United States)

^k UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m Psych Recovery Inc   (United States)

ⁿ BEHAVIORAL RESEARCH CENTER   (United States)

^o NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^p PharmaSite Research Inc   (United States)

^q Brentwood Research Institute   (United States)

^r OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^s UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^t Cyberonics Inc   (Italy)

^u UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Dose response; Treatment durability; Treatment resistant depression; Vagus nerve stimulation; VNS efficacy

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ELECTRIC POTENTIAL; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY CLINICAL ADMINISTERED VERSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PULSE GENERATOR; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

DOSE RESPONSE; TREATMENT DURABILITY; TREATMENT-RESISTANT DEPRESSION; VAGUS NERVE STIMULATION; VNS EFFICACY;

ADULT; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84879288188     PISSN: 1935861X     EISSN: 18764754     Source Type: Journal    
DOI: 10.1016/j.brs.2012.09.013     Document Type: Article

References (33)

1. World Health Organization. Depression. Available from: http://www.who.int/mental-health/management/depression/definition/en/index.html. Accessed 25 October, 2012.
2. R.C. Kessler, M. Petukhova, N.A. Sampson, A.M. Zaslavsky, and H.U. Wittchen Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States Int J Methods Psychiatr Res 21 2012 169 184
3. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, and D. Warden Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry 163 2006 1905 1917
4. Z. Nahas, L.B. Marangell, M.M. Husain, A.J. Rush, H.A. Sackeim, and S.H. Lisanby Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes J Clin Psychiatry 66 2005 1097 1104
5. D.L. Dunner, A.J. Rush, J.M. Russell, M. Burke, S. Woodard, and P. Wingard Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression J Clin Psychiatry 67 2006 688 695
6. L.B. Marangell, A.J. Rush, M.S. George, H.A. Sackeim, C.R. Johnson, and M.M. Husain Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes Biol Psychiatry 51 2002 280 287
7. M.S. George, A.J. Rush, L.B. Marangell, H.A. Sackeim, S.K. Brannan, and S.M. Davis A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression Biol Psychiatry 58 2005 364 373
8. A.J. Rush, H.A. Sackeim, L.B. Marangell, M.S. George, S.K. Brannan, and S.M. Davis Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study Biol Psychiatry 58 2005 355 363
9. A.J. Rush, L.B. Marangell, H.A. Sackeim, M.S. George, S.K. Brannan, and S.M. Davis Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial Biol Psychiatry 58 2005 347 354
10. A.J. Rush, M.S. George, H.A. Sackeim, L.B. Marangell, M.M. Husain, and C. Giller Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study Biol Psychiatry 47 2000 276 286
11. S. Grimm, and M. Bajbouj Efficacy of vagus nerve stimulation in the treatment of depression Expert Rev Neurother 10 2010 87 92
12. J.L. Martin, and E. Martin-Sanchez Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs Eur Psychiatry 27 2012 147 155
13. C. Daban, A. Martinez-Aran, N. Cruz, and E. Vieta Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review J Affect Disord 110 2008 1 15
14. B.N. Gaynes, L. Lux, S. Lloyd, R.A. Hansen, G. Gartlehner, and P. Thieda Nonpharmacologic interventions for treatment-resistant depression in adults 2011 Agency for Healthcare Research and Quality Rockville, MD [cited AHRQ Publication No. 11-EHC056-EF]. Available from: http://www.effectivehealthcare. ahrq.gov/reports/final.cfm
15. A.V. Peterchev, T.A. Wagner, P.C. Miranda, M.A. Nitsche, W. Paulus, and S.H. Lisanby Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices Brain Stimul 5 2011 435 453
16. A. Handforth, C.M. DeGiorgio, S.C. Schachter, B.M. Uthman, D.K. Naritoku, and E.S. Tecoma Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial Neurology 51 1998 48 55
17. The Vagus Nerve Stimulation Study Group A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures Neurology 45 1995 224 230
18. Diagnostic and statistical manual of mental disorders 4th ed. 2000 American Psychiatric Association
19. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, and E. Weiller The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl. 20 1998 22 33 [quiz 4-57]
20. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389
21. ®. Houston, TX: Cyberonics, Inc.
22. A.J. Rush, T.J. Carmody, and P. Reimitz The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms Int J Meth Psychiatr Res 9 2000 45 95
23. A.J. Rush, M.H. Trivedi, H.M. Ibrahim, T.J. Carmody, B. Arnow, and D.N. Klein The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression Biol Psychiatry 54 2003 573 583
24. W. Guy ECDEU assessment manual for psychopharmacology 1976 US Department of Health, Education, and Welfare Rockville, MD
25. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
26. H.A. Sackeim, S.K. Brannan, A.J. Rush, M.S. George, L.B. Marangell, and J. Allen Durability of antidepressant response to vagus nerve stimulation (VNS) Int J Neuropsychopharmacol 10 2007 817 826
27. M. Bajbouj, A. Merkl, T.E. Schlaepfer, C. Frick, A. Zobel, and W. Maier Two-year outcome of vagus nerve stimulation in treatment-resistant depression J Clin Psychopharmacol 30 2010 273 281
28. US Food and Drug Administration. Neurological panel meeting on clinical trial design on depression trials. October 8, 2010. Available from: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/ucm202072.htm.
29. P.E. Holtzheimer, M.E. Kelley, R.E. Gross, M.M. Filkowski, S.J. Garlow, and A. Barrocas Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression Arch Gen Psychiatry 69 2012 150 158
30. H.A. Sackeim, J. Prudic, D.P. Devanand, P. Decina, B. Kerr, and S. Malitz The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression J Clin Psychopharmacol 10 1990 96 104
31. C.R. Conway, J.T. Chibnall, S. Gangwani, M.A. Mintun, J.L. Price, and T. Hershey Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: A potential marker for response? J Affect Disord 139 2012 283 290
32. Conway CR. VNS neuroimaging: functional imaging to understand response and mechanism of action. Philadelphia, PA: Society of Biological Psychiatry; 04 May 2012. [67th annual scientific convention and program].
33. A.M. Lozano, P. Giacobbe, C. Hamani, S.J. Rizvi, S.H. Kennedy, and T.T. Kolivakis A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression J Neurosurg 116 2012 315 322